Tag Archives: WCCT Global

Gary Nabors: CSC Arm to Assess New Compounds for NIH’s Anti-Infectives Program

A Computer Sciences Corp. (NYSE: CSC) company has won a 10-year, $90 million follow-on contract to examine infectious disease therapeutics for the National Institutes of Health’s anti-infectives program. DynPort Vaccine Company LLC will conduct first phase clinical trials of new compounds to support the National Institute of Allergy and Infectious …

Read More »